Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Author: Chuck Carmen

Epilepsy biomarkers pave way for noninvasive diagnosis, better treatments

Researchers have identified a unique metabolic signature associated with epileptic brain tissue that causes seizures. The chemical biomarker can be detected noninvasively using technology based on magnetic resonance imaging. It will allow physicians to precisely identify small regions of abnormal brain tissue in early-stage epilepsy patients that can’t be detected today using current technol...

Potential Surgery Treatment for Certain Epilepsy Patients, Review Says

A technique called MRI-guided laser interstitial thermal therapy (MgLiTT) may be a potential treatment for epilepsy patients, according to a recent review. Researchers say that MgLiTT may be a particularly viable option for patients whose seizures are caused by tumor-like bodies affecting the hypothalamus, which are difficult to treat with traditional surgery.

Health & Wellness: Detecting childhood epilepsy — it’s not their attention span

Sometimes Shelby would be there, but not “all there.” At the dinner table, her parents and siblings would catch her “zoning out”; she’d stop paying attention to the conversation and need to be jostled back to focus. They’d chide her for being so rude, then continue with their meal. It was just one of her quirks, they reasoned, and she’d grow out of it eventually.

Surgery in Older Patients with Drug-resistant Focal Epilepsy Still Effective, Study Finds

Researchers studied the medical records of patients with drug-resistant focal epilepsy who underwent surgery for the disorder at the age of 50 or older and found that the treatment was as effective as it was for patients younger than 50. However, there was a higher risk of complications from the procedure.

Autism: Which children respond to oxytocin treatment?

Oxytocin treatment has been proven efficient in improving the social behavior of some children with autism, studies have found. A new clinical trial investigates which children will respond best to this treatment and why. Autism is a developmental disability that often leads to struggles in communication, reduced empathy, and social inadaptability to a greater or lesser degree.

Ultra-Marathon Cyclist Who Is Epileptic Breaks Two World Indoor Distance Records

An ultra-marathon cyclist with epilepsy has broken world indoor-track records for the longest distances covered in six and eight hours. Katie Ford dedicated the records she broke on July 2 at the Sir Chris Hoy Velodrome in Glasgow’s Emirates Arena to raising epilepsy awareness.

Stereo EEG provides a deep, detailed map of the brain as physicians evaluate patients for the surgical treatment of epilepsy.

For patients that find their seizures difficult to manage on medications, other treatment options such as diet, devices or surgery may be beneficial. Dr. Amy Crepeau, neurologist at Mayo Clinic in Arizona, discusses the evaluation of patients with epilepsy using brain mapping technology.

How an autism gene mutation alters brain development

By analyzing the brains of mice, researchers have discovered how mutations in a gene called CHD8 may alter brain development and cognitive functioning to cause autism. Researchers from the United States and Canada found that CHD8 gene mutations altered gene expression in mice, impairing their cognitive functioning and increasing brain volume. Both of these characteristics are present in humans wit...

What is the vagus nerve?

The vagus nerve is the longest and most complex of the 12 pairs of cranial nerves that emanate from the brain. It transmits information to or from the surface of the brain to tissues and organs elsewhere in the body. The name “vagus” comes from the Latin term for “wandering.” This is because the vagus nerve wanders from the brain into organs in the neck, chest, and abdomen.

FDA Approves VNS Therapy Treatment for Drug-Resistant Epilepsy in Children as Young as Four Years Old

It was announced today that the FDA approves VNS Therapy® system (“VNS Therapy”) in patients as young as four years of age with partial onset seizures that are refractory to antiepileptic medications. This groundbreaking achievement makes VNS Therapy the first and only device that is FDA approved for drug-resistant epilepsy in this pediatric population. Previously, VNS Therapy was FDA approved for...

Nearly Half of Persons With Epilepsy Forget to Take Their Meds at Least Once a Month, Poll Shows

Almost half of epilepsy patients surveyed in a British poll say they’ve forgotten to take their medications at least once in the past month. Researchers at Epilepsy Research UK wanted to know how meticulously people receiving their newsletter adhere to medication regimes. They stress, however, that these results pertain to a sample of 125 respondents and that the poll is still active. Medication a...

Anti-epilepsy drug restores normal brain activity in mild Alzheimer’s disease

Feasibility study suggests suppressing seizure-like activity may help patients – Beth Israel Deaconess Medical Center In the last decade, mounting evidence has linked seizure-like activity in the brain to some of the cognitive decline seen in patients with Alzheimer’s disease. Patients with Alzheimer’s disease have an increased risk of epilepsy and nearly half may experience subc...

Lost Password

Register